Premia Global Advisors’s Pediatrix Medical MD Stock Holding History

Premia Global Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,041	Closed	-$28K	–	243
2019 Q1	$28K	Buy	+1,041	New	+$34.9K	0.03%	261
2018 Q2	–	Sell	-675	Closed	-$37K	–	297
2018 Q1	$37K	Hold	675	–	–	0.03%	228
2017 Q4	$36K	Buy	+675	New	+$31.8K	0.03%	234

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Premia Global Advisors's MD Position: Q2 2019 in Review

Premia Global Advisors sold out of Pediatrix Medical (MD) in Q2 2019, closing a stake of 1,041 shares — an estimated $28K sold.

Premia Global Advisors first reported a position in MD in Q4 2017 and held it in 3 quarters. The position peaked at $37K in Q1 2018. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

Premia Global Advisors reported no remaining Pediatrix Medical position as of Q2 2019 after selling out during the quarter.
Premia Global Advisors sold 1,041 Pediatrix Medical shares in Q2 2019, an estimated $28K.
Premia Global Advisors first reported a position in Pediatrix Medical in Q4 2017 and held it in 3 quarters.
Premia Global Advisors's Pediatrix Medical position peaked at $37K in Q1 2018.
247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on Premia Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.